# US 2010/0136110 A1 · Granular pharmaceutical composition for oral administration

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0136110 A1
- Document ID: US20100136110A1
- Status: Published application
- Kind: A1
- Application number: 12/568,257
- Filed: 2009-09-28
- Published: 2010-06-03
- Earliest claimed: 2008-09-30
- Assignees: Astellas Pharma Inc.
- Inventors: Hiroaki Tasaki; Atsushi Maeda; Takeshi Yano; Kazuhiro Sako
- Web page: https://patentgrep.com/patent/US20100136110A1

## CPC

- A61K 9/0056: {Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals}
- A61K 9/5073: {having two or more different coatings optionally including drug-containing subcoatings}
- A61P 3/06: Antihyperlipidemics
- A61P 13/08: of the prostate
- A61P 19/10: for osteoporosis
- A61P 25/28: for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

A granular pharmaceutical composition for oral administration, wherein a drug-containing particle is coated with a coating comprising a methyl methacrylate-butyl methacrylate-dimethylaminoethyl methacrylate copolymer and a water-soluble polymer is disclosed.

## Claims

### Claim 1

A granular pharmaceutical composition for oral administration, wherein a drug-containing particle is coated with a coating comprising a methyl methacrylate-butyl methacrylate-dimethylaminoethyl methacrylate copolymer and a water-soluble polymer.

### Claim 2 (depends on 1)

The granular pharmaceutical composition for oral administration according to claim 1, wherein the coating further comprises a glidant.

### Claim 3 (depends on 1)

The granular pharmaceutical composition for oral administration according to claim 1, wherein the water-soluble polymer is one compound, or two or more compounds selected from the group consisting of hydroxypropyl cellulose, hydroxypropyl methylcellulose, methylcellulose, hydroxyethyl cellulose, povidone, copolyvidone, a polyvinyl alcohol-polyethylene glycol graft copolymer, polyvinyl alcohol, macrogol, and polyethylene oxide.

### Claim 4 (depends on 1)

The granular pharmaceutical composition for oral administration according to claim 1, wherein the water-soluble polymer is one compound, or two or more compounds selected from the group consisting of hydroxypropyl cellulose, hydroxypropyl methylcellulose, methylcellulose, and hydroxyethyl cellulose.

### Claim 5 (depends on 1)

The granular pharmaceutical composition for oral administration according to claim 1, wherein an amount of the water-soluble polymer is 1% by weight to 30% by weight with respect to an amount of the methyl methacrylate-butyl methacrylate-dimethylaminoethyl methacrylate copolymer.

### Claim 6 (depends on 2)

The granular pharmaceutical composition for oral administration according to claim 2, wherein the glidant is one compound, or two or more compounds selected from the group consisting of metal silicates, silicon dioxides, higher fatty acid metal salts, metal oxides, alkaline earth metal salts, and metal hydroxides.

### Claim 7 (depends on 2)

The granular phamaceutical composition for oral administration according to claim 2, wherein the glidant is one compound, or two or more compounds selected from the group consisting of talc, kaolin, calcium silicate, magnesium silicate, light anhydrous silicic acid, magnesium stearate, calcium stearate, iron oxide, titanium oxide, calcium carbonate, calcium phosphate, gypsum, magnesium carbonate, aluminum hydroxide, hydrated silicon dioxide, microcrystalline cellulose, synthetic aluminum silicate, heavy anhydrous silicic acid, aluminum magnesium hydroxide, stearic acid, corn starch, magnesium aluminate metasilicate, dibasic calcium phosphate fine granulated, and glyceryl monostearate.

### Claim 8 (depends on 2)

The granular pharmaceutical composition for oral administration according to claim 2, wherein the glidant is one compound, or two or more compounds selected from the group consisting of talc, kaolin, calcium silicate, magnesium silicate, light anhydrous silicic acid, magnesium stearate, and glyceryl monostearate.

### Claim 9 (depends on 2)

The granular pharmaceutical composition for oral administration according to claim 2, wherein an amount of the glidant is 1% by weight to 500% by weight with respect to an amount of the methyl methacrylate-butyl methacrylate-dimethylaminoethyl methacrylate copolymer.

### Claim 10 (depends on 1)

The granular pharmaceutical composition for oral administration according to claim 1, wherein the water-soluble polymer is hydroxypropyl methylcellulose, and an amount of hydroxypropyl methylcellulose is 1% by weight to 30% by weight with respect to an amount of the methyl methacrylate-butyl methacrylate-dimethylaminoethyl methacrylate copolymer.

### Claim 11 (depends on 1)

The granular pharmaceutical composition for oral administration according to claim 1, wherein the drug is an acidic drug or a salt thereof.

### Claim 12 (depends on 1)

The granular pharmaceutical composition for oral administration according to claim 1, wherein the drug has an unpleasant taste.

### Claim 13 (depends on 1)

The granular pharmaceutical composition for oral administration according to claim 1, wherein (1) a coating layer containing (i) a coating consisting of a methyl methacrylate-butyl methacrylate-dimethylaminoethyl methacrylate copolymer and a water-soluble polymer, or (ii) a coating consisting of a methyl methacrylate-butyl methacrylate-dimethylaminoethyl methacrylate copolymer, a water-soluble polymer, and a glidant surrounds (2) a layer comprising one, or two or more water-soluble insolubilizers and one, or two or more water-soluble insolubilizing substances.

### Claim 14 (depends on 1)

A rapidly disintegrating tablet in the buccal cavity, comprising the granular pharmaceutical composition for oral administration according to claim 1.

### Claim 15

A process of manufacturing a granular pharmaceutical composition for oral administration, characterized by coating a drug-containing particle with a coating comprising a methyl methacrylate-butyl methacrylate-dimethylaminoethyl methacrylate copolymer and a water-soluble polymer.

### Claim 16 (depends on 15)

The process according to claim 15, wherein the coating further comprises a glidant.

### Claim 17 (depends on 15)

The process according to claim 15, wherein the water-soluble polymer is one compound, or two or more compounds selected from the group consisting of hydroxypropyl cellulose, hydroxypropyl methylcellulose, methylcellulose, hydroxyethyl cellulose, povidone, copolyvidone, a polyvinyl alcohol-polyethylene glycol graft copolymer, polyvinyl alcohol, macrogol, and polyethylene oxide.

### Claim 18 (depends on 16)

The process according to claim 16, wherein the glidant is one compound, or two or more compounds selected from the group consisting of metal silicates, silicon dioxides, higher fatty acid metal salts, metal oxides, alkaline earth metal salts, and metal hydroxides.

### Claim 19 (depends on 1)

A process of manufacturing the granular pharmaceutical composition for oral administration according to claim 1, comprising the steps of:
(1) forming a layer comprising a water-soluble insolubilizer and a water-soluble insolubilizing substance outside a drug-containing particle, and
(2) coating the obtained particle with (i) a coating consisting of a methyl methacrylate-butyl methacrylate-dimethylaminoethyl methacrylate copolymer and a water-soluble polymer, or (ii) a coating consisting of a methyl methacrylate-butyl methacrylate-dimethylaminoethyl methacrylate copolymer, a water-soluble polymer, and a glidant.

### Claim 20

(canceled)
